Acl-12 is a recombinant, full-length enzyme derived from Caenorhabditis elegans (nematode worm), expressed in E. coli with an N-terminal His-tag. It belongs to the 1-acyl-sn-glycerol-3-phosphate acyltransferase (AGPAT) family, which catalyzes the acylation of lysophosphatidic acid (LPA) to form phosphatidic acid (PA), a critical precursor for glycerophospholipid biosynthesis .
| Parameter | Value |
|---|---|
| Species | Caenorhabditis elegans |
| Source | E. coli |
| Tag | N-terminal His-tag |
| Protein Length | Full-length (1–391 amino acids) |
| Purity | >90% (SDS-PAGE) |
| Storage Buffer | Tris/PBS-based buffer with 6% trehalose, pH 8.0 |
| Gene ID | Q11087 (UniProt) |
| Synonyms | LPAAT, 1-AGPAT, Lysophosphatidic acid acyltransferase |
Acl-12 functions as an acyltransferase, transferring acyl groups from fatty acyl-CoA to the sn-2 position of LPA, yielding PA. This reaction is essential for de novo phospholipid synthesis and lipid signaling .
Substrate Specificity: Prefers polyunsaturated fatty acyl-CoAs (e.g., eicosapentaenoyl-CoA) over saturated or monounsaturated donors .
Membrane Topology: Predicted to localize to the cytosolic side of the endoplasmic reticulum (ER) or mitochondrial membrane, with catalytic motifs exposed to the cytosol .
Acl-12 contains conserved acyltransferase motifs (I–IV), critical for acyl-CoA binding and catalysis. These motifs are structurally similar to human AGPAT isoforms (e.g., AGPAT1, AGPAT2) .
Motif I: Cytosolic, involved in acyl acceptor (LPA) binding .
Motif IV: Deep within the membrane, facilitating acyl-CoA interaction .
Acl-12 was purified using detergent-based methods (e.g., 6-cyclohexyl-1-hexyl-β-d-maltoside) to maintain solubility and activity. Enzymatic assays with [14C]oleoyl-CoA and LPA demonstrated robust activity, with a preference for unsaturated fatty acids .
| Substrate | Activity (Relative Units) | Reference |
|---|---|---|
| Eicosapentaenoyl-CoA | 100% (highest) | |
| Linoleoyl-CoA | 85% | |
| Palmitoyl-CoA | 50% |
Acl-12 shares functional similarities with bacterial PlsC (e.g., Shewanella livingstonensis) and mammalian AGPATs, though substrate preferences vary. For example, P. falciparum PfLPLAT1 (a parasitic homolog) exhibits dual LPAAT/LPCAT activity but prefers polyunsaturated acyl donors .
| Feature | Acl-12 | Human AGPAT2 | PfLPLAT1 |
|---|---|---|---|
| Primary Substrate | LPA | LPA | LPA, LPC |
| Acyl-CoA Preference | Polyunsaturated | Saturated/monounsaturated | Polyunsaturated |
| Localization | ER/mitochondria | ER | ER (parasite) |
Acl-12 contributes to phospholipid homeostasis and signaling. In C. elegans, its dysregulation may affect membrane fluidity, development, or stress responses .
Lipid Engineering: Used to produce polyunsaturated phospholipids in E. coli .
Drug Targeting: Potential candidate for modulating lipid metabolism in parasitic pathogens (e.g., Plasmodium) .
This recombinant Putative 1-acyl-sn-glycerol-3-phosphate acyltransferase acl-12 (acl-12) catalyzes the conversion of lysophosphatidic acid (LPA) to phosphatidic acid by acylating the sn-2 position of the glycerol backbone.
Acyltransferases such as acl-12 catalyze a fundamental step in glycerolipid biosynthesis by transferring fatty acyl groups from acyl-CoA donors to glycerol-3-phosphate (G3P) acceptor molecules. This reaction is critical for:
Formation of membrane phospholipids essential for cellular architecture
Synthesis of storage lipids like triglycerides
Production of signaling molecules derived from lysophosphatidic acid (LPA)
In eukaryotic systems, most G3P acyltransferases (GPATs) acylate the sn-1 position to produce 1-acyl-LPA, which serves as a precursor for the generation of phosphatidic acid and subsequent lipid species. The positional specificity of acylation (sn-1 versus sn-2) can significantly influence the downstream fate of the lipid intermediates and their biological functions .
The optimal expression and purification protocol for recombinant acl-12 involves:
Expression System:
Host: E. coli (commonly used for acl-12 expression)
Vector: Expression vector with N-terminal His-tag
Full-length construct: Amino acids 1-391 of acl-12 protein
Purification Method:
Cell lysis under appropriate buffer conditions
Affinity chromatography using Ni-NTA resin (leveraging the His-tag)
Elution with imidazole gradient
Buffer exchange to remove imidazole
Storage as lyophilized powder
Reconstitution Protocol:
Centrifuge vial before opening to bring contents to the bottom
Reconstitute in deionized sterile water to 0.1-1.0 mg/mL
Add glycerol to 5-50% final concentration (default 50%)
Aliquot for long-term storage at -20°C/-80°C
Determining the regiospecificity of acyltransferases such as acl-12 requires specialized analytical techniques to distinguish between sn-1 and sn-2 acylation:
Borate-TLC Method:
Conduct enzymatic reaction with [14C]G3P as acyl acceptor and specific acyl-CoAs as donors
Spot reaction products directly onto borate-impregnated TLC plates
Develop plates with appropriate solvent systems
Borate-TLC allows resolution of MAG α and β isomers with minimal acyl migration
Compare migration patterns with chemically synthesized sn-1 and sn-2 MAG standards
GC-MS Confirmation:
Perform large-scale enzymatic assays
Recover bands corresponding to putative products from borate-TLC
Silylate samples to improve volatility
Analyze by GC-MS
Compare EI-MS spectra and retention times with synthetic standards
Include appropriate controls (empty vector, omission of substrate)
Several complementary analytical techniques are essential for comprehensive characterization of acl-12 substrate specificity:
Radiometric Assays:
Utilize [14C]G3P as radioactive substrate with various acyl-CoA donors
Separate reaction products by thin-layer chromatography
Visualize and quantify radioactive products using phosphorimaging
Calculate enzyme activity based on product formation rate
Mass Spectrometry-Based Approaches:
Liquid chromatography-mass spectrometry (LC-MS) for non-radioactive analysis
Multiple reaction monitoring (MRM) for targeted quantification of specific products
High-resolution MS for detailed structural characterization
Kinetic Analysis:
Determine Km and Vmax values for different acyl-CoA substrates
Construct substrate saturation curves
Compare catalytic efficiency (kcat/Km) across substrate range
Comparative sequence analysis of acyltransferases has revealed several highly conserved motifs critical for catalytic function, including three motifs identified in mammalian AGPATs:
Conserved Motifs in AGPATs:
| Motif | Consensus Sequence | Proposed Function |
|---|---|---|
| I | KX₂LX₆GX₁₂R | Acyl-CoA binding |
| II | [Unknown in search results] | Likely G3P binding |
| III | [Unknown in search results] | Catalytic residues |
These conserved motifs serve as potential targets for site-directed mutagenesis to elucidate structure-function relationships in acl-12. Mutations in these conserved regions typically result in significant reduction or loss of enzymatic activity, as demonstrated in related enzymes. For example, site-directed mutagenesis of putative active-site residues in plant GPAT6 nearly eliminated its phosphatase activity, altering the product profile from predominantly MAGs to 2-acyl-LPA .
Some acyltransferases exhibit bifunctional activity, possessing both acyltransferase and phosphatase domains. To distinguish and characterize these activities:
Product Analysis Strategy:
Conduct enzymatic reactions with [14C]G3P and appropriate acyl-CoA substrates
Separate reaction products into phosphorylated (LPA) and dephosphorylated (MAG) fractions
Quantify the ratio of LPA to MAG to assess relative activities
Compare with enzymes known to possess only acyltransferase activity
Domain Mutagenesis Approach:
Identify putative phosphatase domain through sequence homology
Generate site-directed mutants of conserved residues
Assay mutants for selective loss of phosphatase activity while retaining acyltransferase function
Analyze product profiles (LPA vs. MAG ratio) as indicators of functional alterations
Inhibitor Studies:
Apply selective phosphatase inhibitors
Monitor differential effects on acyltransferase versus phosphatase activities
Establish inhibitor profiles characteristic of bifunctional enzymes
Phylogenetic analysis of acyltransferases reveals interesting evolutionary patterns that provide context for understanding acl-12's function:
Evolutionary Distribution:
Classical membrane-bound eukaryotic GPATs preferentially acylate the sn-1 position
Plant-specific GPATs (GPAT4-6) exhibit distinctive sn-2 acylation preference
Bifunctional acyltransferase-phosphatase activity appears to be a specialized adaptation
Taxonomic Restrictions:
Close homologs of plant-specific GPATs with sn-2 preference exist in all land plants
These specialized GPATs are absent in animals (including C. elegans), fungi, and microorganisms
The emergence of these enzymes likely facilitated plant adaptation to terrestrial environments through synthesis of protective exterior polyesters (cutin and suberin)
The evolutionary placement of acl-12 within this framework suggests it likely belongs to the classical eukaryotic GPAT family with sn-1 positional preference, consistent with its annotation as a 1-acyl-sn-glycerol-3-phosphate acyltransferase .
Multiple expression systems offer distinct advantages for functional characterization of acl-12:
E. coli Expression System:
Advantages: Rapid growth, high yield, simple purification
Limitations: Lacks eukaryotic post-translational modifications
Best for: Initial biochemical characterization, structural studies
Protocol modifications: Lower induction temperature (16-18°C) often improves solubility
Yeast Expression Systems:
Advantages: Eukaryotic processing, amenable to complementation studies
Specific application: Expression in GPAT-deficient mutants (e.g., gat1Δ) allows direct assessment of acl-12 function through rescue experiments
Analytical approach: Monitor lipid profile changes using mass spectrometry
Cell-Free Translation Systems:
Advantages: Rapid expression, avoids toxicity issues
Example: Wheat germ cell-free translation system has been successfully employed for acyltransferase expression
Applications: Ideal for rapid screening of mutants or substrate specificity studies
Accurate enzyme kinetic measurements for acl-12 require careful optimization of multiple parameters:
Assay Optimization Variables:
pH (typically 7.0-8.0 for most acyltransferases)
Temperature (25-37°C range)
Divalent cation concentration (Mg²⁺, Mn²⁺)
Detergent type and concentration (critical for membrane-associated enzymes)
Substrate concentrations (both G3P and acyl-CoA)
Kinetic Parameter Determination:
Initial velocity measurements under varying substrate concentrations
Lineweaver-Burk, Eadie-Hofstee, or non-linear regression analysis
Determination of Km, Vmax, and kcat values
Product inhibition studies to elucidate reaction mechanism
Common Methodological Challenges:
Limited solubility of long-chain acyl-CoA substrates
Product solubility and detection limitations
Potential for acyl migration in MAG products
Mixed micelle formation affecting actual substrate concentration
Comparative analysis between acl-12 and mammalian AGPATs reveals important functional relationships:
Regulatory Differences:
Mammalian AGPATs show transcriptional regulation by PPARα, as evidenced by 25% lower cardiac mAGPAT activities in PPARα null mice
When treated with clofibrate (a PPARα activator), cardiac mAGPAT activities were 50% lower in PPARα null mice compared to wild-type animals
These activity changes corresponded with altered mRNA levels of specific AGPAT isoforms (enhanced mAGPAT3, reduced mAGPAT2)
Functional Implications:
Total AGPAT activity may be regulated both by the relative abundance of different isoforms and by the expression level of each isoform
Differential substrate preferences among isoforms likely influence lipid composition
Understanding the regulatory mechanisms of acl-12 in C. elegans could provide models for studying AGPAT regulation in higher organisms
Several complementary experimental approaches can help determine the physiological roles of acl-12 in C. elegans:
Genetic Manipulation Strategies:
CRISPR/Cas9-mediated gene knockout or knockdown
RNAi-mediated silencing
Transgenic overexpression
Generation of point mutations in conserved motifs
Phenotypic Analysis Methods:
Lipidomic profiling using LC-MS/MS to detect alterations in glycerophospholipid compositions
Membrane fluidity analysis using fluorescence anisotropy
Developmental timing assessments
Reproductive capacity and brood size measurements
Lifespan and stress resistance evaluations
Tissue-Specific Expression Analysis:
Creation of GFP-fusion constructs to visualize expression patterns
Tissue-specific promoters to drive targeted expression
Immunohistochemistry with specific antibodies
Single-cell RNA sequencing to determine expression in specific cell types
Several significant challenges must be addressed when translating acl-12 research findings:
Translational Challenges:
Structural and functional differences between acl-12 and mammalian homologs
Species-specific regulation of enzyme activity and expression
Integration of acyltransferase function within complex lipid metabolic networks
Limited availability of specific inhibitors for targeted modulation
Potential Applications Despite Challenges:
Platform for screening acyltransferase modulators
Model system for studying membrane lipid homeostasis
Bioengineering applications for modified lipid production
Insights into evolutionary conservation of lipid metabolism
Methodological Approaches to Address Challenges: